In addition, AKT phosphorylation was not effectively inhibited following treatment with lapatinib in HER2-positive breast cancer cells overexpressing TYRO3 [40] and coincident inhibition of TYRO3 expression and AKT phosphorylation was observed in ovarian cancer cells following treatment with N-acetyl cysteine [57]. The gene discussed is TYRO3; the disease is ovarian cancer.